Exact Sciences Tag

[caption id="attachment_17713" align="alignright" width="227"] Exact Sciences CEO Kevin Conroy[/caption] Cancer is detected too late. Today, a staggering 70% of incident cancers have no routine early detection tests. As a result, most patients are diagnosed after they develop signs and symptoms of their disease. These “symptom-detected” cancers...

Madison-headquartered Exact Sciences Corp. announced that it has entered into a collaboration agreement with the National Surgical Adjuvant Breast and Bowel Project (NSABP), a cooperative group founded by the National Cancer Institute. Together, Exact Sciences and the NSABP will conduct a prospective, multicenter validation study with stage...

Madison cancer diagnostics company Exact Sciences Corp. is working on a test that would screen for multiple types of cancer with a single blood draw. It’s aiming to help people catch early-stage cancer so it can be treated quickly. The test passed proof of concept in a 10,000-person...

A recent study of around 300 COVID-19 patients in Wisconsin found that vaccinated people had similar levels of viral particles in their nasal passages as those who were unvaccinated. The study from UW-Madison, Exact Sciences and Public Health Madison and Dane County suggests that those...